ZSWIM6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.205400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.178800E-01
Normal-vs-Stage2
3.917400E-01
Normal-vs-Stage3
6.188300E-02
Normal-vs-Stage4
6.511400E-01
Stage1-vs-Stage2
7.332800E-01
Stage1-vs-Stage3
3.309600E-01
Stage1-vs-Stage4
4.028000E-01
Stage2-vs-Stage3
2.614800E-01
Stage2-vs-Stage4
6.170000E-01
Stage3-vs-Stage4
1.152650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.628000E-01
Normal-vs-AfricanAmerican
6.599600E-01
Normal-vs-Asian
7.048600E-01
Caucasian-vs-AfricanAmerican
5.877000E-01
Caucasian-vs-Asian
3.172800E-01
AfricanAmerican-vs-Asian
9.009800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.592600E-01
Normal-vs-Female
2.858600E-01
Male-vs-Female
9.899400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.856000E-01
Normal-vs-Age(41-60Yrs)
6.911000E-01
Normal-vs-Age(61-80Yrs)
2.134600E-01
Normal-vs-Age(81-100Yrs)
8.361600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.246400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.708200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.380400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.239100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.863900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.806410E-01
Normal-vs-Daily Drinker
1.516760E-01
Normal-vs-Weekly Drinker
5.029400E-01
Normal-vs-Occasional Drinker
4.616400E-01
Normal-vs-Social Drinker
4.132600E-01
Non Drinker-vs-Daily Drinker
5.941200E-01
Non Drinker-vs-Weekly Drinker
7.130800E-01
Non Drinker-vs-Occasional Drinker
3.627800E-01
Non Drinker-vs-Social Drinker
1.679820E-01
Daily Drinker-vs-Weekly Drinker
4.627800E-01
Daily Drinker-vs-Occasional Drinker
2.144800E-01
Daily Drinker-vs-Social Drinker
8.924200E-02
Weekly Drinker-vs-Occasional Drinker
8.013800E-01
Weekly Drinker-vs-Social Drinker
6.055400E-01
Occasional Drinker-vs-Social Drinker
7.311800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.751600E-02
Normal-vs-Grade 2
1.697670E-03
Normal-vs-Grade 3
1.075980E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.894200E-02
Grade 1-vs-Grade 3
8.884000E-02
Grade 1-vs-Grade 4
8.751600E-02
Grade 2-vs-Grade 3
7.787400E-01
Grade 2-vs-Grade 4
1.697670E-03
Grade 3-vs-Grade 4
1.075980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.356400E-01
Normal-vs-NonDiabetic
2.502000E-01
Diabetic-vs-NonDiabetic
8.133800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.571840E-01
Normal-vs-NoPancreatitis
2.918200E-01
Pancreatitis-vs-NoPancreatitis
6.948000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.864800E-01
Normal-vs-N1
3.341800E-01
N0-vs-N1
5.903200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.948800E-01
Normal-vs-TP53-NonMutant
3.379000E-01
TP53-Mutant-vs-TP53-NonMutant
7.983000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
